UncategorizedAlignment of data requirements to facilitate new antibiotics development
EMA, FDA and PMDA held a second tripartite meeting in Vienna on 26-27 April 2017. The main topic were regulatory approaches for the evaluation of antiobacterial agents and differences of data requirements. It is important to unify requirements in clinical trials industry in order to provide similar requirements for pharmaceutical companies conducting those trials...